On the Right Path with NuPathe, Inc.?

From Trading Tips
January 22, 2013 - 4:34pm

It’s common for the share price of a small-cap issue to rise sharply in the wake of a significant FDA approval for one of its drugs. In the case of NuPathe, Inc., the FDA’s recent approval of the company’s migraine headache patch called Zecurity caused a short-lived stock price pop, and then a pull back [...]

Share this article »  

Continue reading this article »